Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Paller Amy S., Seyger Marieke M. B., Magariños Gabriel A., Pinter Andreas, Cather Jennifer C., Rodriguez-Capriles Claudia, Zhu Danting, Somani Najwa, Garrelts Alyssa, Papp Kim A., Kollaborációs szervezet: IXORA-PEDS Investigators, Kemény Lajos, et al
2022